[1]
U. K. Sarker, “Randomized, open-label, two-way crossover bioequivalence study of Novirax (Drug International Ltd, Bangladesh) compared with Zovirax (Glaxo Wellcome, UK) – two brands of Acyclovir – in healthy male volunteers”, Asian J Pharm Res Dev, vol. 9, no. 3, pp. 6–10, Jun. 2021.